{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:47:26Z","timestamp":1755226046770,"version":"3.43.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>This study aims to investigate the expression pattern of human chorionic gonadotropin (hCG) in the tissue of endometrioid type endometrial cancer (EEC) using immunohistochemistry, and also to investigate the effect of hCG expression pattern on prognosis and survival in EEC. We evaluated patients who were operated between 2010 and 2020 in the obstetrics and gynecology clinic of our center due to EEC. In total, 194 women were determined to be in either the hCG-negative group (n=137) or the hCG-positive group (n=57). The detection rate of deep myometrial invasion (16.8% vs. 36.8%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.002), lymphovascular space invasion (10.9% vs. 24.6%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.015), and metastatic lymph node (6.7% vs. 21.8%; <jats:italic toggle=\"yes\">P<\/jats:italic>= 0.003) in patients with hCG-positive staining were analyzed to be significantly higher. Five-year disease-free survival (DFS) (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.015) and overall survival (OS) (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.024) rates were found to be higher in the hCG-negative group. hCG expression was found to be an independent risk factor for recurrence, and DFS in grade I-II EEC was limited to the uterus and with superficial myometrial invasion (low risk). No independent risk factors for OS were analyzed. hCG positivity is a risk factor with poor prognostic factors in endometrial cancer. It was concluded that hCG expression in low-risk EEC is a valuable negative prognostic factor for recurrence and DFS.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001102","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:01:09Z","timestamp":1737993669000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Role of hCG Expression in Endometrial Cancer Prognosis"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-8305","authenticated-orcid":false,"given":"Varol","family":"G\u00fclseren","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Dolanbay","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"\u00c7a\u011fli","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Da\u011fgez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahit","family":"Topalo\u011flu","sequence":"additional","affiliation":[{"name":"Medical Pathology, Faculty of Medicine, Erciyes University, Kayseri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Medical Pathology, Faculty of Medicine, Erciyes University, Kayseri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"\u00d6z\u00e7elik","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim Serdar","family":"Serin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"G\u00fcng\u00f6rd\u00fck","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Mu\u011fla Sitki Ko\u00e7man University, Mu\u011fla, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"R1-20250127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R2-20250127","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R3-20250127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"},{"key":"R4-20250127","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/13697137.2010.550974","article-title":"Endometrial cancer, types, prognosis, female hormones and antihormones","volume":"14","author":"Ulrich","year":"2011","journal-title":"Climacteric"},{"key":"R5-20250127","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N Engl J Med"},{"key":"R6-20250127","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5301\/ijbm.5000290","article-title":"The importance of hCG in human endometrial adenocarcinoma and breast cancer","volume":"33","author":"K\u00f6lbl","year":"2018","journal-title":"Int J Biol Markers"},{"key":"R7-20250127","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2006.02.019","article-title":"Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis","volume":"260-262","author":"Iles","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R8-20250127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2006.11.015","article-title":"The gonadotropins: tissue-specific angiogenic factors?","volume":"269","author":"Reisinger","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R9-20250127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2007.04.006","article-title":"Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG)","volume":"272","author":"Viswanath","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R10-20250127","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7827-10-24","article-title":"hCG, the wonder of today\u2019s science","volume":"10","author":"Cole","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"R11-20250127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2010.07.014","article-title":"Does hCG or hCG\u03b2 play a role in cancer cell biology","volume":"329","author":"Iles","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"R12-20250127","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/IGC.0b013e3181bbe933","article-title":"Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia","volume":"20","author":"Jankowska","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20250127","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ijgc-2023-004279","article-title":"Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?","volume":"33","author":"Daggez","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R14-20250127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"Endometrial Cancer Staging Subcommittee, FIGO Women\u2019s Cancer Committee. FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-20250127","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1095\/biolreprod57.5.1202","article-title":"Presence of functional luteinizing hormone\/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer","volume":"57","author":"Lojun","year":"1997","journal-title":"Biol Reprod"},{"key":"R16-20250127","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2008.08.018","article-title":"hLH\/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer","volume":"111","author":"Noci","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R17-20250127","doi-asserted-by":"crossref","first-page":"1618056","DOI":"10.1155\/2018\/1618056","article-title":"Luteinizing hormone\/human chorionic gonadotropin receptor immunohistochemical score associated with poor prognosis in endometrial cancer patients","volume":"2018","author":"Sorbi","year":"2018","journal-title":"Biomed Res Int"},{"key":"R18-20250127","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1038\/s41598-021-87492-5","article-title":"Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses","volume":"11","author":"Lottini","year":"2021","journal-title":"Sci Rep"},{"key":"R19-20250127","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/mcpr.2002.0421","article-title":"Increased expression of human luteinizing hormone\/human chorionic gonadotropin receptor mRNA in human endometrial cancer","volume":"16","author":"Ji","year":"2002","journal-title":"Mol Cell Probes"},{"key":"R20-20250127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1460001","article-title":"Biology of the gonadotropin-releasing hormone system in gynecological cancers","volume":"146","author":"Gr\u00fcndker","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"R21-20250127","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fonc.2016.00190","article-title":"LH\/hCG-receptor expression may have a negative prognostic value in low-risk endometrial cancer","volume":"6","author":"Noci","year":"2016","journal-title":"Front Oncol"},{"key":"R22-20250127","first-page":"1483","article-title":"Increased expression of luteinizing hormone\/human chorionic gonadotropin receptor gene in human endometrial carcinomas","volume":"79","author":"Lin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20250127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R24-20250127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"R25-20250127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000486770","article-title":"B Subunit of human chorionic gonadotropin promotes tumor invasion and predicts poor prognosis of early-stage colorectal cancer","volume":"45","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R26-20250127","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/ijms18071587","article-title":"Human chorionic gonadotropin and breast cancer","volume":"18","author":"Sch\u00fcler-Toprak","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R27-20250127","first-page":"351","article-title":"Human chorionic gonadotropin-beta in endometrium cancer tissue","volume":"25","author":"Nowak-Markwitz","year":"2004","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:01:22Z","timestamp":1737993682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001102","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"type":"print","value":"0277-1691"},{"type":"electronic","value":"1538-7151"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}